Hydroxyzine Pamoate and Hydroxyzine Hydrochloride Are Clinically Equivalent for As-Needed Anxiety
There is no clinically meaningful difference between hydroxyzine pamoate and hydroxyzine hydrochloride for as-needed anxiety treatment—they are bioequivalent formulations of the same active drug, and the choice should be based solely on availability and cost. 1
Understanding the Formulations
Both formulations deliver the same active medication (hydroxyzine) but differ only in their salt forms:
- Hydroxyzine pamoate is the embonate salt, typically available in capsule form
- Hydroxyzine hydrochloride is the hydrochloride salt, available in tablets and liquid formulations
According to FDA labeling, hydroxyzine pamoate capsules are specifically dosed as equivalents to hydroxyzine hydrochloride (e.g., "25 mg hydroxyzine pamoate equivalent to 25 mg hydroxyzine hydrochloride"). 1 This means manufacturers have already accounted for any molecular weight differences, making the dosing identical between formulations.
Evidence for Hydroxyzine in Anxiety
While the evidence base for hydroxyzine is limited, available research suggests:
- Hydroxyzine is more effective than placebo for generalized anxiety disorder (OR 0.30,95% CI 0.15 to 0.58), though the quality of evidence is limited by high risk of bias in included studies 2
- Hydroxyzine shows equivalent efficacy to benzodiazepines and buspirone in head-to-head comparisons 2
- Acceptability and tolerability are reasonable, with no significant difference in dropout rates compared to placebo 2
Practical Considerations
The main side effect is sedation/drowsiness, which is actually the mechanism by which hydroxyzine provides anxiolytic effects (it's an antihistamine, not a true anxiolytic). 2 This makes it most appropriate for:
- As-needed use when sedation is acceptable or desired
- Nighttime dosing for anxiety with concurrent sleep disturbance
- Short-term use (evidence for long-term efficacy is lacking) 3
Dosing for as-needed anxiety:
- Start with 25-50 mg as needed
- Can increase to 50-100 mg if needed and tolerated 4, 2
- Effects typically occur within 30-60 minutes
Important Caveats
- Hydroxyzine is NOT a first-line treatment for anxiety disorders. Current guidelines prioritize SSRIs, SNRIs, and cognitive behavioral therapy for generalized anxiety, social anxiety, separation anxiety, and panic disorder 5
- The evidence supporting hydroxyzine is of low to moderate quality with high risk of bias 2
- Hydroxyzine should not be used long-term as a primary anxiety treatment—it's best reserved for acute, as-needed symptom management 3
- Avoid in patients with QT prolongation risk or those taking other sedating medications
Bottom Line
Choose whichever formulation (pamoate or hydrochloride) is available and affordable—they work identically. The capsule form (pamoate) versus tablet form (hydrochloride) may influence patient preference, but this is the only practical difference. For sustained anxiety management, transition patients to evidence-based first-line treatments (SSRIs/SNRIs with or without CBT) rather than relying on hydroxyzine long-term.